Cargando…
Safer opioid distribution in response to the COVID-19 pandemic
COVID-19 has turned the world upside down in a very short period of time. The impact of COVID-19 will disproportionately effect people who are least able to protect themselves and this will include people who use drugs. The arrival of the COVID-19 pandemic comes at time when North America is in the...
Autor principal: | Tyndall, Mark |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier B.V.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7383133/ https://www.ncbi.nlm.nih.gov/pubmed/32739148 http://dx.doi.org/10.1016/j.drugpo.2020.102880 |
Ejemplares similares
-
‘Safer opioid distribution’ as an essential public health intervention for the opioid mortality crisis – Considerations, options and examples towards broad-based implementation
por: Fischer, Benedikt, et al.
Publicado: (2020) -
Treatment of prescription opioid disorders in Canada: looking at the ‘other epidemic’?
por: Fischer, Benedikt, et al.
Publicado: (2016) -
A Dental Response to the COVID-19 Pandemic—Safer Aerosol-Free Emergent (SAFER) Dentistry
por: Benzian, Habib, et al.
Publicado: (2020) -
Reevaluating chronic opioid monitoring during and after the COVID-19 pandemic
por: Rao, Prashant N, et al.
Publicado: (2020) -
Better science for safer medicines: the human imperative
por: Archibald, Kathy, et al.
Publicado: (2018)